The Jiang lab studies the cellular and molecular basis of human neural development and pathogenesis of neurological disorders by using human patient-derived induced pluripotent stem cells (a.k.a. iPSCs). We create iPSC-based in vitro cerebral organoid model and in vivo human-mouse chimeric brain model to investigate mechanisms underlying neurodevelopmental disorders (e.g, Down syndrome, autism spectrum disorder), as well as age-related neurodegenerative diseases (e.g., Alzheimer's disease). In addition, human iPSCs hold great promise for developing cell therapies to replace damaged brain cells and restore brain functions after CNS injury. We also study how to derive functionally competent neural cells, particularly macroglial and microglial cells, from human iPSCs for neural repair. The basic and translational stem cell research we are pursuing critically bridges between the understanding of human neural development and degeneration in normal and diseased conditions, and the development of stem cell medicine to treat neurological disorders.
Program Faculty
- Peng Jiang
- Associate Professor
- Department: Department of Cell Biology and Neuroscience
- Graduate Program(s): Cell and Developmental Biology
- Major Research Interest(s): Aging, Developmental Biology, Neurological disease, Neuroscience, Stem Cells, Regeneration, and Tissue Injury
- Research Techniques: Cell Biology, Fluorescent and super resolution microscopy, Genetic engineering, Single Cell RNA Techniques, Transcriptomics
- Research Organism(s): Cell lines, Humans
- Phone: 1.8484452805
- Email:
This email address is being protected from spambots. You need JavaScript enabled to view it. - School of Arts and Sciences
- Division of Life Sciences
- Nelson Biology Laboratories, Room B209
- 604 Allison Road
- Piscataway, NJ 08854-8000
- Key Words: Stem cells as a model of brain development and disease, stem cell regenerative medicine for neural repair
- Lab Site URL
- News Items: Gene Mutation Leading to Autism Found to Overstimulate Brain Cells, Rutgers Scientists Reveal New Evidence of Key Mechanism in Alzheimer’s, Targeting Key Gene Could Help Lead to Down Syndrome Treatment